Sign inJoin waitlistJoin the waitlist

Changqing Xie

Physician · Frederick Health Hospital

Credentials: · · · · · ·

History

Frederick Health Hospital
2025–Present

Medical Oncology Fellow
2019–2021
Hematology and Medical Oncology
Clinical Center at the National Institutes of Health
2016–2019
Internal Medicine
ECU Health Medical Center
2013–2016
Doctor of Medicine
1999–2003

Research

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma
Cancer immunology · 2019 · 107 citations
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research · 2020 · First of 19 authors · 84 citations
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer
Case report · Hepatology · 2019 · First of 24 authors · 81 citations

Tim Greten
21 papers
David Kleiner
13 papers
BW
Brad Wood
12 papers
William Figg
10 papers
DH
Donna Hrones
9 papers
AD
Austin Duffy
8 papers
EL
Elliot Levy
8 papers
Gagandeep Brar
8 papers
Jonathan Hernandez
4 papers
Rajiv Trehan
4 papers · 4 as a fellow
CL
Chunwei Lai
3 papers · 1 as a fellow
Freddy Escorcia
3 papers

Grants

Cancer Stem Cells in Cholangiocarcinoma
National Cancer Institute · ZIA
Contact PI · $3.4M · Division of Basic Sciences - Nci

Clinical trials

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032